Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
Go back to Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 45.72 -0.13 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.85 | 52 Week High | $4.38 | |||
| Open | $45.54 | 52 Week Low | $1.88 | |||
| Day High | $45.80 | P/E | N/A | |||
| Day Low | $45.24 | EPS | $-1.12 | |||
| Volume | 25,705 | |||||
